HHS Awards $16.9M for Clinical Trial Development, Primarily to Large Firms
Contract Overview
Contract Amount: $16,940,109 ($16.9M)
Contractor: Sanofi Pasteur Vaxdesign Corp
Awarding Agency: Department of Health and Human Services
Start Date: 2010-07-30
End Date: 2020-09-29
Contract Duration: 3,714 days
Daily Burn Rate: $4.6K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 6
Pricing Type: FIRM FIXED PRICE
Sector: R&D
Official Description: TAS::75 0140::TAS CLINICAL TRIAL IN A TEST TUBE FOR MEDICAL COUNTERMEASURE DEVELOPMENT
Place of Performance
Location: ORLANDO, ORANGE County, FLORIDA, 32826
State: Florida Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $16.9 million to SANOFI PASTEUR VAXDESIGN CORP for work described as: TAS::75 0140::TAS CLINICAL TRIAL IN A TEST TUBE FOR MEDICAL COUNTERMEASURE DEVELOPMENT Key points: 1. Spending focused on R&D in Biotechnology, a critical sector for national health security. 2. Competition was full and open, suggesting a robust price discovery process. 3. The contract was awarded as a firm fixed price, providing cost certainty. 4. No small business participation was noted, indicating potential for future outreach.
Value Assessment
Rating: good
The contract value of $16.9M over 10 years appears reasonable for specialized R&D. Benchmarking against similar biotechnology research contracts would provide further validation.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
Full and open competition was utilized, allowing multiple vendors to bid. This method generally leads to competitive pricing and ensures the government receives the best value.
Taxpayer Impact: The competitive nature of the award suggests taxpayer funds were used efficiently, securing specialized research services at a market-driven price.
Public Impact
Supports development of medical countermeasures, enhancing public health preparedness. Investment in biotechnology R&D can lead to long-term health security advancements. Contract duration of nearly 10 years indicates a significant, long-term research commitment.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Lack of small business participation.
- Long contract duration may warrant periodic reviews.
Positive Signals
- Firm fixed price contract provides cost predictability.
- Full and open competition ensures market-based pricing.
- Supports critical R&D for national health security.
Sector Analysis
This contract falls under Research and Development in Biotechnology (NAICS 541711), a high-value sector often characterized by long development cycles and significant intellectual property. Spending benchmarks for similar R&D contracts vary widely based on scope and duration.
Small Business Impact
The contract was not awarded to small businesses, as indicated by 'sb': false. Future solicitations in this area could explore opportunities to increase small business involvement in critical research and development.
Oversight & Accountability
The contract was awarded by the Department of Health and Human Services (HHS), Office of Assistant Secretary for Preparedness and Response (ASPR), suggesting oversight by an agency focused on health security. The long duration may necessitate robust program management and oversight.
Related Government Programs
- Research and Development in Biotechnology
- Department of Health and Human Services Contracting
- Office of Assistant Secretary for Preparedness and Response Programs
Risk Flags
- Lack of small business participation.
- Long contract duration.
- Potential for scope creep in R&D projects.
- Dependence on specific research outcomes.
Tags
research-and-development-in-biotechnolog, department-of-health-and-human-services, fl, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $16.9 million to SANOFI PASTEUR VAXDESIGN CORP. TAS::75 0140::TAS CLINICAL TRIAL IN A TEST TUBE FOR MEDICAL COUNTERMEASURE DEVELOPMENT
Who is the contractor on this award?
The obligated recipient is SANOFI PASTEUR VAXDESIGN CORP.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).
What is the total obligated amount?
The obligated amount is $16.9 million.
What is the period of performance?
Start: 2010-07-30. End: 2020-09-29.
What specific medical countermeasures were developed under this contract, and what is their current readiness level?
The provided data does not specify the exact medical countermeasures developed. Further analysis would require reviewing contract performance reports and deliverables to assess the specific outcomes and their stage of development, such as pre-clinical, Phase I, or Phase II readiness.
How does the cost per year of this contract compare to similar long-term biotechnology R&D efforts?
The contract's total value is $16.9M over approximately 10 years, averaging around $1.69M per year. Comparing this to similar long-term biotechnology R&D contracts requires access to a broader dataset of comparable awards, considering factors like research scope, therapeutic area, and developmental phase.
Were there any specific performance metrics or milestones tied to the firm fixed price to ensure effective research progress?
While the contract type is 'FIRM FIXED PRICE', the data doesn't detail specific performance metrics or milestones. Typically, such contracts include detailed statements of work with deliverables and milestones. Reviewing the contract's statement of work would be necessary to confirm the presence and nature of these performance indicators.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 6
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 12612 CHALLENGER PKWY STE 365, ORLANDO, FL, 32826
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $26,561,461
Exercised Options: $16,940,109
Current Obligation: $16,940,109
Contract Characteristics
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Cost or Pricing Data: YES
Timeline
Start Date: 2010-07-30
Current End Date: 2020-09-29
Potential End Date: 2020-09-29 00:00:00
Last Modified: 2019-09-27
More Contracts from Sanofi Pasteur Vaxdesign Corp
- Accelerated Vaccine Creation and Testing — $25.6M (Department of the Interior)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →